2022 / 01

DOI: 10.24075/medet.2022.042

REVIEW

Aspects of informing and obtaining consent while conducting trials in pulmonology and psychiatry

Sinitsina II, Nenascheva NM, Peredelskaya MYu, Sosin DN
About authors

Russian Medical Academy of Continuous Professional Training, Moscow, Russia

Correspondence should be addressed: Irina I. Sinitsina
ul. Barrikadnaya, 2/1, str. 1, Moscow, 125993, Russia; ur.liam@aniri-anistinis

About paper

Author contribution: Sinitsina II — preparing a manuscript for publication, literature analysis, editing, writing an introduction, abstract and ‘Vulnerable participants or patients’ section; Nenascheva NM — preparing a manuscript for publication, analysis of literature for ‘Specific nature of obtaining informed consent from patients with bronchial asthma and chronic obstructive pulmonary disease’ section; Peredelskaya MYu — preparing a manuscript for publication, analysis of literature for ‘Specific nature of obtaining informed consent from patients with bronchial asthma and chronic obstructive pulmonary disease’ section; Sosin DN — preparing a manuscript for publication, analysis of literature for ‘Specific nature of obtaining informed consent from psychiatric patients’ section.

Received: 2022-01-22 Accepted: 2022-02-25 Published online: 2022-03-30
|
  1. Lileeva EG, Speshilova SA, Sinicina OA, Demarina SM. Eticheskie aspekty issledovanij bioekvivalentnosti. Opyt raboty klinicheskogo centra. Medicinskaya etika. 2020; (1): 43–49.
  2. Melihov OG. Klinicheskie issledovaniya. 2-e izdanie. 2007. Russian.
  3. Nishimura A, Carey J, Erwin PJ, et al. Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials. BMC Med Ethics. 2013; (28): 14. Available from URL: https://DOI.org/10.1186/1472–6939–14–28.
  4. Malysheva EA, Mokhov OI. Informed consent in clinical drug trials. Quality clinical practice. 2002; (1): 6–13. Russian.
  5. Good clinical practice. Declaration of Helsinki by the World Medical Association. 2006; 15. Russian.
  6. Chetta A, Foresi A, Marangio E, Olivieri D. Psychological Implications of Respiratory Health and Disease. Respiration. 2005; (72): 210–215. Available from URL: DOI: 10.1159/000084056.
  7. Clark DM. A cognitive approach to panic. Behav Res Ther. 1986; (24): 461–70.
  8. Celli B, Blasi F, Gaga M, et al. Perception of symptoms and quality of life — comparison of patients’ and physicians’ views in the COPD MIRROR study. Int J Chron Obstruct Pulmon Dis. 2017; (12): 2189–96.
  9. Wong SS, Abdullah N, Abdullah A, Liew SM, Ching SM, Khoo EM, Jiwa M, Chia YC. Unmet needs of patients with chronic obstructive pulmonary disease (COPD): a qualitative study on patients and doctors. BMC FamPract. 2014 Apr 16; (15): 67. Available from URL: DOI: 10.1186/1471–2296–15–67. PMID: 24739595; PMCID: PMC3996170.
  10. Kvangarsnes M, Torheim H, Hole T, Öhlund LS. Narratives of breathlessness in chronic obstructive pulmonary disease. J ClinNurs. 2013; 22 (21–22): 3062–3070. Available from URL: DOI:10.1111/jocn.12033.
  11. Santus P, Radovanovic D, Pellegrino G, et al. Doctor-patient relationship: A resource to improve respiratory diseases management. Eur J Intern Med. 2012; (23): 442–6.
  12. Lunn S, Dharmagunawardena R, Lander M, Sweeney J. It’s hard to talk about breathlessness: a unique insight from respiratory trainees. Clin Med (Lond). 2019; 19 (4): 344–347. Available from URL: DOI:10.7861/clinmedicine.19–4–344.
  13. Oh H, Stickley A, Singh F, Koyanagi A. Self-reported asthma diagnosis and mental health: findings from the Collaborative Psychiatric Epidemiology Surveys. PsychiatryRes. 2019 Jan; (271): 721–5.
  14. Feldman JM, Siddique MI, Morales E, Kaminski B, Lu SE, Lehrer PM. Psychiatric disorder and asthma outcomes among high-risk inner-city patients. Psychosom Med. 2005 Nov-Dec; 67 (6): 989–96.
  15. Bouchard A, Ouellet K, Bacon SL, Lavoie KL. Psychiatric morbidity in COPD and asthma patients presenting to the emergency room for acute exacerbations. Paper presented at: 17th Annual Meeting of the International Society for Advancement of Respiratory Psychophysiology. New York City, NY. 2010 September 25–27.
  16. Fisher JA. Pharmaceutical Paternalism and the Privatization of Clinical Trials. [dissertation]. Troy, NY: Rensselaer Polytechnic Institute, 2005.
  17. Fisher JA. “Ready-to-Recruit” or “Ready-to-Consent” Populations: Informed Consent and the Limits of Subject Autonomy. QualInq. 2007 Sep; 13 (6): 875–894. Available from URL: DOI: 10.1177/1077800407304460. PMID: 21359125; PMCID: PMC3044324.
  18. Lima OM, Oliveira-Souza R, Santos Oda R, Moraes PA, Sá LF, Nascimento OJ: Subclinical encephalopathy in chronic obstructive pulmonary disease. ArqNeuropsiquiatr. 2007; (65): 1154–1157. Available from URL: https://DOI.org/10.1590/S0004– 282X2007000700012.
  19. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD European Respiratory Journal. 2010; 35 (4): 913–22. Available from URL: DOI: 10.1183/09031936.00125109.
  20. Li J, Huang Y, Fei GH. The Evaluation of Cognitive Impairment and Relevant Factors in Patients with Chronic Obstructive Pulmonary Disease. Respiration. 2013; (85): 98–105. Available from URL: DOI: 10.1159/000342970.
  21. Tam NT. et al. Participants’ understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis. Bulletin of the World Health Organization. 2015; (93): 186–198.
  22. Paul S Appelbaum. Decisional Capacity of Patients with Schizophrenia to Consent to Research: Taking Stock. Schizophr Bull. 2006 Jan; 32 (1): 22–25. Published online 2005 Sep 21. Available from URL: 10.1093/schbul/sbi063; PMCID: PMC2632185; PMID:16177275.
  23. Carpenter WT, Gold JM, Lahti AC, et al. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiat. 2000; 57: 533–538.
  24. Dilip V Jeste, Colin A Depp, Barton W Palmer. Magnitude of Impairment in Decisional Capacity in People With Schizophrenia Compared to Normal Subjects: An Overview. Schizophr Bull. 2006 Jan; 32 (1): 121–128. Published online 2005 Sep 28. Available from URL: DOI:10.1093/schbul/sbj001; PMC2632179.
  25. Dunn LB. Capacity to consent to research in schizophrenia: the expanding evidence base. Behav Sci Law. 2006; 24 (4): 431–45. Available from URL: DOI: 10.1002/bsl.698.PMID:16883608.
  26. Palmer BW. Informed consent for schizophrenia research: what is an investigator (or IRB) to do Behav Sci Law. 2006; 24 (4): 447– 52. Available from URL: DOI: 10.1002/bsl.695. PMID:16883620.
  27. Kovnick JA, Appelbaum PS, Hoge SK, Leadbetter RA. Competence to consent to research among long-stay in patients with chronic schizophrenia. Psychiatr Serv. 2003 Sep; 54 (9): 1247–52. Available from URL: DOI: 10.1176/appi.ps.54.9.1247.
  28. Moser DJ, Schultz SK, Arndt S, et al. Capacity to Provide Informed Consent for Participation in Schizophrenia and HIV Research. Am J Psychiatry. 2002; 159: 1201–7.
  29. Palmer BW, Dunn LB, Appelbaum PS, et al. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Arch Gen Psychiatry. 2005 Jul; 62 (7): 726– 33. Available from URL: DOI: 10.1001/archpsyc.62.7.726.
  30. Parmigiani G, Mandarelli G, Dacquino C, et al. Decisional Capacity to Consent to Clinical Research Involving Placebo in Psychiatric Patients. J Forensic Sci. 2016 Mar; 61 (2): 388–393. Available from URL: DOI: 10.1111/1556–4029.13000.Epub 2015 Dec 22.PMID:27404612.
  31. De Renzo EG, Conley RR, Love R. Assessment of capacity to give consent to research participation: state-of-the-art and beyond. the Care Law Policy. 1998; 1 (1): 66–87. PMID:15573430.
  32. Swartz MS, Stroup TS, McEvoy JP. What CATIE Found: Results From the Schizophrenia Trial. Available from URL: DOI:10.1176/ ps.2008.59.5.500. PMID:18451005.
  33. Wirshing DA, Sergi MJ, Mintz J. A videotape intervention to enhance the informed consent process for medical and psychiatric treatment research. Am J Psychiatry. 2005 Jan; 162(1): 186–8. Available from URL: DOI: 10.1176/appi.ajp.162.1.186. PMID:15625221.
  34. Dunn LB, Lindamer LA, Palmer BW, et al. Enhancing comprehension of consent for research in older patients with psychosis: a randomized study of a novel consent procedure. Am J Psychiatry. 2001 Nov; 158 (11): 1911–3. Available from URL: DOI: 10.1176/appi.ajp.158.11.1911; PMID:11691700
  35. Lileeva EG, Speshilova SA, Sinitsina OA, Demarina SM. Ethical aspects of bioequivalence studies. Clinical experience. Medical ethics. 2020; (1): 43–49.